Tenecteplase
Educational summary, not a formulary. Dosing is quoted from the Makindo chapters and topics site. The other sections are draft summaries not yet checked line by line against the BNF or SPC. Check dose, indication, interactions and monitoring in the BNF entry for Tenecteplase and local guidelines before prescribing.
Thrombolytic
Mechanism
Fibrin-specific thrombolytic.
Uses
STEMI when primary PCI not available, acute ischaemic stroke (selected).
Dosing
- Tenecteplase | Single IV bolus 30–50 mg by weight band; consider half dose if ≥75 years.
Cardiology: Ischaemic Heart Disease (ACS) - Tenecteplase , a single weight-based bolus (0.25 mg/kg, maximum 25 mg) - now widely used.
Neurology: Stroke Emergencies - Tenecteplase Ischaemic stroke | Single IV bolus, 0.25 mg/kg (maximum 25 mg); within 4.5 hours.
Neurology: Stroke Emergencies
Side effects
Bleeding, intracranial haemorrhage, reperfusion arrhythmia.
Interactions
Anticoagulants and antiplatelets.
Contraindications and cautions
Active bleeding, recent surgery, prior intracranial haemorrhage
Monitoring
ECG, BP, neurological status
Pregnancy and breastfeeding
Use only if life-threatening
Renal and hepatic impairment
No adjustment
Overdose and reversal
Tranexamic acid for bleeding
Special advice
Weight-banded single bolus; stroke use per local pathway.
More from the textbook: uses, cautions and other points
- Where drugs act - aspirin (COX-1), clopidogrel/prasugrel/ticagrelor (P2Y12), warfarin (vitamin K-dependent factors II, VII, IX, X), heparins (antithrombin), apixaban/rivaroxaban/edoxaban (Xa), dabigatran (thrombin), alteplase/tenecteplase (plasminogen).
Cardiology: Anatomy Physiology and Pharmacology - Mechanism - recombinant tissue plasminogen activators ( alteplase , tenecteplase ) convert plasminogen to plasmin , which dissolves fibrin clot.
Cardiology: Anatomy Physiology and Pharmacology - Alteplase / tenecteplase | Plasminogen activators; STEMI without timely PCI, massive PE, stroke; bleeding.
Cardiology: Anatomy Physiology and Pharmacology - Fibrinolysis (e.g. tenecteplase, weight-adjusted) if PPCI cannot be delivered in time: give with an antithrombin, then transfer for angiography - immediately if ST elevation has not resolved by 60–90 minutes ( rescue PCI ).
Cardiology: Cardiology Emergencies - Tenecteplase (preferred): a single IV bolus over 5–10 seconds, weight-based. A half dose should be considered in patients aged 75 or over to reduce intracranial haemorrhage.
Cardiology: Ischaemic Heart Disease (ACS) - Weight | Tenecteplase dose
Cardiology: Ischaemic Heart Disease (ACS) - Ninety minutes after tenecteplase, a patient still has pain and less than 50% ST resolution. Answer: Failed reperfusion. Arrange urgent rescue PCI; do not repeat the fibrinolytic.
Cardiology: Ischaemic Heart Disease (ACS) - Alteplase / tenecteplase | Thrombolysis within 4.5 hours; haemorrhage; BP under 185/110; no antithrombotics for 24 hours.
Neurology: Anatomy, Physiology and Pharmacology
Where it is discussed in the book
- Cardiology: Anatomy Physiology and Pharmacology (3 mentions)
- Cardiology: Cardiology Emergencies (1 mention)
- Cardiology: Ischaemic Heart Disease (ACS) (4 mentions)
- Neurology: Anatomy, Physiology and Pharmacology (1 mention)
- Neurology: Stroke Emergencies (5 mentions)
- Haematology: Anatomy Physiology and Pharmacology (3 mentions)
- Acute Medicine: Reduced consciousness, seizures, headache and acute confusion (2 mentions)
- Clinical imaging: Neuroimaging — head, brain and spine (1 mention)
- Integrated cardiology chapter (4 mentions)
- Pathology: Haemodynamic disorders, thrombosis, embolism and atherosclerosis (1 mention)